SG49772A1 - Thrombin receptor antagonists - Google Patents

Thrombin receptor antagonists

Info

Publication number
SG49772A1
SG49772A1 SG1996005407A SG1996005407A SG49772A1 SG 49772 A1 SG49772 A1 SG 49772A1 SG 1996005407 A SG1996005407 A SG 1996005407A SG 1996005407 A SG1996005407 A SG 1996005407A SG 49772 A1 SG49772 A1 SG 49772A1
Authority
SG
Singapore
Prior art keywords
thrombin receptor
receptor antagonists
hydrophobic radical
linkages
formula
Prior art date
Application number
SG1996005407A
Other languages
English (en)
Inventor
Robert M Scarborough
Original Assignee
Cor Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cor Therapeutics Inc filed Critical Cor Therapeutics Inc
Publication of SG49772A1 publication Critical patent/SG49772A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG1996005407A 1992-07-30 1993-07-08 Thrombin receptor antagonists SG49772A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92234092A 1992-07-30 1992-07-30
US8078893A 1993-06-28 1993-06-28

Publications (1)

Publication Number Publication Date
SG49772A1 true SG49772A1 (en) 1998-06-15

Family

ID=26763931

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996005407A SG49772A1 (en) 1992-07-30 1993-07-08 Thrombin receptor antagonists

Country Status (10)

Country Link
US (1) US5866681A (fr)
EP (1) EP0656008B1 (fr)
JP (1) JP2675438B2 (fr)
AT (1) ATE190625T1 (fr)
AU (1) AU669922B2 (fr)
CA (1) CA2140543C (fr)
DE (1) DE69328104T2 (fr)
IL (1) IL106197A (fr)
SG (1) SG49772A1 (fr)
WO (1) WO1994003479A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063847A (en) 1997-11-25 2000-05-16 Schering Corporation Thrombin receptor antagonists
EP1036072B1 (fr) * 1997-11-25 2004-05-06 Schering Corporation Antagonistes de recepteur de thrombine
DK1054892T3 (da) * 1998-02-19 2003-01-20 Ortho Mcneil Pharm Inc Azolpeptidmimetiske forbindelser som thrombinreceptorantagonister
US6017890A (en) * 1998-02-19 2000-01-25 Ortho-Mcneil Pharmaceutical, Inc. Azole peptidomimetics as thrombin receptor antagonists
GB2356198A (en) 1999-10-29 2001-05-16 Merck & Co Inc Isoxazole thrombin receptor antagonists
US6515023B2 (en) 2000-01-31 2003-02-04 Merck & Co., Inc. Thrombin receptor antagonists
US6403612B2 (en) 2000-01-31 2002-06-11 Merck & Co., Inc. Thrombin receptor antagonists
PE20020235A1 (es) 2000-06-15 2002-04-02 Schering Corp Derivados de nor-seco himbacina como antagonistas de los receptores de trombina
US7235567B2 (en) 2000-06-15 2007-06-26 Schering Corporation Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
JP2005506949A (ja) 2000-12-20 2005-03-10 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー ケモカイン受容体の調節剤としてのジアミン
CA2432369A1 (fr) 2000-12-20 2002-08-08 Bristol-Myers Squibb Pharma Company Derives cycliques en tant que modulateurs de l'activite des recepteurs de chimiokines
US20040096443A1 (en) * 2002-03-08 2004-05-20 Traynelis Stephen Francis Treatment of neurodegenerative diseases and conditions using par1 antagonists
HUP0500443A3 (en) 2001-10-18 2009-12-28 Schering Corp Himbacine analogues as thrombin receptor antagonists and pharmaceutical compositions containing them
IL164376A0 (en) * 2002-04-03 2005-12-18 Applied Research Systems Ox4or binding agents, their preparation and pharmaceutical compositions containing them
SI2065384T1 (sl) 2002-04-16 2011-05-31 Schering Corp Tricikliäśni trombin receptor antagonist
US7074765B2 (en) 2003-05-01 2006-07-11 The Regents Of The University Of Michigan Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
JP4558788B2 (ja) * 2004-05-28 2010-10-06 シェーリング コーポレイション トロンビンレセプターアンタゴニストとしての条件付きヒンバシンアナログ
MX2007004197A (es) 2004-10-08 2007-06-15 Schering Corp Antagonistas del receptor de trombina.
AU2006230292A1 (en) 2005-03-31 2006-10-05 Schering Corporation Spirocyclic thrombin receptor antagonists
WO2007126771A2 (fr) 2006-03-29 2007-11-08 Schering Corporation Dérivés d'himbacine monocycliques et bicycli ques utiles en tant qu'antagonistes du récepteur de la thrombine
AU2007238756A1 (en) 2006-04-13 2007-10-25 Schering Corporation Fused ring thrombin receptor antagonists
US8022088B2 (en) 2006-06-29 2011-09-20 Schering Corporation Substituted bicyclic and tricyclic thrombin receptor antagonists
AU2007305269A1 (en) 2006-10-04 2008-04-10 Schering Corporation Bicyclic and tricyclic derivatives as thrombin receptor antagonists
BRPI0809095A2 (pt) * 2007-03-23 2014-09-09 Schering Corp Redução de eventos adversos após intervenção percutânea através de uso de um antagonista de receptor de trombina
WO2008128038A2 (fr) * 2007-04-13 2008-10-23 The Scripps Research Institute Procédés et compositions permettant de traiter les dysfonctionnements cardiaques
WO2009143039A2 (fr) 2008-05-19 2009-11-26 Schering Corporation Composés hétérocycliques en tant qu'inhibiteurs du facteur ixa
TWI393716B (zh) 2009-08-04 2013-04-21 Merck Sharp & Dohme 作為ｉｘａ因子抑制劑之雜環化合物
EP2335717A1 (fr) 2009-11-16 2011-06-22 Institut National De La Recherche Agronomique Antagonistes PAR-1 pour une utilisation dans le traitement ou la prévention d'infections par le virus de la grippe de type A
EP2822557B1 (fr) 2012-03-06 2017-08-23 Merck Sharp & Dohme Corp. Préparation et utilisation de dérivés bicycliques d'himbacine en tant qu'antagonistes du récepteur de par
EP3035929B1 (fr) 2013-08-22 2024-07-03 Merck Sharp & Dohme LLC Dérivés bicycliques de 7a-amide substitué-6,6-difluoro himbacine
US9808473B2 (en) 2013-08-22 2017-11-07 Merck Sharp & Dohme Corp. Preparation and use of 3-pyridyl substituted-6,6-difluoro bicyclic himbacine derivatives as par-1 receptor antagonists
WO2015026685A1 (fr) 2013-08-22 2015-02-26 Merck Sharp & Dohme Corp. Dérivés bicycliques de 7a-hétérocycle substitué-6,6-difluoro himbacine
US9969724B2 (en) 2014-04-16 2018-05-15 Merck Sharp & Dohme Corp. Factor IXa inhibitors
WO2022018156A1 (fr) 2020-07-22 2022-01-27 Janssen Pharmaceutica Nv Composés utiles en tant qu'inhibiteurs du facteur xia
US11814364B2 (en) 2021-03-18 2023-11-14 Janssen Pharmaceutica Nv Pyridine N-oxide derivatives useful as factor XIa inhibitors
US11845748B2 (en) 2021-03-18 2023-12-19 Janssen Pharmaceutica Nv Bicyclic pyridine N-oxide derivatives useful as a factor XIa inhibitors
US11919881B2 (en) 2021-03-18 2024-03-05 Janssen Pharmaceutica Nv Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitors
US11897880B2 (en) 2021-04-30 2024-02-13 Janssen Pharmaceutica Nv 7,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitors
US11958856B2 (en) 2021-07-22 2024-04-16 Janssen Pharmaceutica Nv Substituted 1,2,3,8,9,9a-hexahydro-5H-pyrrolo[1,2-a]azepin-5-ones as factor XIa inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2589720A1 (fr) * 1985-11-14 1987-05-15 Aubaniac Jean Ensemble prothetique pour l'articulation du genou
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US5256766A (en) * 1991-02-19 1993-10-26 The Regents Of The University Of California Recombinant thrombin receptor and related pharmaceuticals
WO1993018141A1 (fr) * 1992-03-02 1993-09-16 Biogen, Inc. Antagonistes de recepteur de thrombine

Also Published As

Publication number Publication date
JP2675438B2 (ja) 1997-11-12
IL106197A0 (en) 1994-05-30
CA2140543C (fr) 2001-04-10
CA2140543A1 (fr) 1994-02-17
AU669922B2 (en) 1996-06-27
WO1994003479A1 (fr) 1994-02-17
ATE190625T1 (de) 2000-04-15
JPH07506115A (ja) 1995-07-06
IL106197A (en) 1999-11-30
DE69328104D1 (de) 2000-04-20
EP0656008B1 (fr) 2000-03-15
DE69328104T2 (de) 2000-12-21
EP0656008A1 (fr) 1995-06-07
US5866681A (en) 1999-02-02
AU4668593A (en) 1994-03-03

Similar Documents

Publication Publication Date Title
IL106197A0 (en) Thrombin receptor antagonists
DE3378052D1 (en) Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
ECSP930999A (es) Nuevos compuestos utilizables como agentes edulcorantes, su procedimiento de preparacion
AP9801312A0 (en) 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor anatagonist.
MY107756A (en) Piperazine derivatives.
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
WO2000059497A8 (fr) Modulateurs de pyrrolidine de l'activite du recepteur des chimiokines
ATE230390T1 (de) Dithiocarbamyl-derivate geeignet als schmiermitteladditive
HU9501754D0 (en) Dolostatin analog
DK0773956T3 (da) Renset form for streptograminer, fremstilling deraf og farmaceutiske sammensætninger, der indeholder denne
ATE216375T1 (de) Aminothiazole derivate, ihre herstellung und sie enthaltenden pharmazeutischen zusammensetzungen
DE69425804D1 (en) Phosphonsäurediesterderivate
NZ336793A (en) Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture
ES2129123T3 (es) Nuevo derivado de bisoxadiazolidina.
ATE30429T1 (de) Acylamino-oxo- oder hydroxy-substituiertealkylamino thiazine und thiazepine.
MX9500228A (es) N-oxidos de 4-arilpiperazinas y 4-arilpiperidinas.
NZ208996A (en) 5-substituted(1,2,4 triazpyrimidin-2-amine derivatives and pharmaceutical compositions
AU7837791A (en) 3,7-diazabicyclo(3,3,1)nonane compounds useful as diuretics
IE861361L (en) Bicyclic amino acid derivatives.
JPS6485998A (en) Acylated splenopentine, manufacture and use
IL94979A0 (en) Antiherpes pentapeptides and their preparation
ES2053701T3 (es) Mezcla de norborneno con duracion prolongada de uso.
ES557263A1 (es) Procedimiento para la obtencion de alanincompuestos n-sustituidos
ES8402820A1 (es) 4-difenilmetil-1-((oxoalquil)imino)metil-piperidinas y sus derivados.
EP0687257A1 (fr) 4-amino-2-(hetero)aryl-butanamides utiles comme antagonistes de la 5-ht1a